XXX has successfully expanded the production capacity of the mammalian GMP facility.

XXX heeft de productiecapaciteit van de met zoogdiercellen werkende (biofarmaceutische) GMP-faciliteit met succes uitgebreid.

Uitleg:

Naar mijn mening duidt "mammalian" op het SOORT GMP-faciliteit,
het heeft te maken met de productiemethode.
Het wil zeggen dat de faciliteit bij de productie exclusief gebruik maakt van zoogdiercellen/culturen ("mammalian" in tegenstelling tot "microbial or insect cells" bijvoorbeeld).

Google steunt deze veronderstelling: tik in: "GMP facility" en "mammalian" --> de "mammalian cell lines / cultures etc." vliegen je om de oren:

mammalian cell banks
mammalian cell culture bioreactor
mammalian cell biopharmaceutical facility
“When SynCo was first established, we were mainly producing material for Phase III trials and the commercial market in our existing 1,500-L microbial fermentation-scale GMP facility,” says Joanne McCudden, business development manager. In order to grow the business, SynCo Bio Partners expanded its process and analytical development services to produce biopharmaceuticals for early-phase clinical trials, which require much smaller amounts of material. The new 5,000-sq-ft GMP facility, licensed by the EMEA in 2006, offers 300-L-scale microbial production or 200-L-scale mammalian cell batch or continuous production in wave bioreactors.

Bio Safety Level 2 multi-product mammalian cell culture facility for the production of therapeutic proteins....
The facility, which produces mammalian cell-based therapeutic proteins ....

Facilities for Mammalian Cell Products

"The conference participants who work with mammalian systems benefited from understanding a very different and interesting expression system that has achieved impressive results for monoclonal antibodies and other therapeutic proteins. Glen Williams' extensive experience with mammalian systems provided valuable insights for comparing the LEX System to more conventional cell culture production methods."

As a result of the recent merger to form Biogen Idec, an immediate opportunity exists to sub-lease a turn-key FDA and EMEA licensed GMP biopharmaceutical manufacturing facility complete with installed bioreactors and utilities. The 5,500L mammalian cell culture facility is production-ready, including required permits and validated utilities.

etc.

Om te kunnen voldoen aan de grote vraag naar fermentatiecapiciteit voor op biotechnologie gebaseerde processen zal DSM Biologics de productiecapaciteit uitbreiden met een 2000 liter-fermentatiesysteem voor biofarmaceutica geproduceerd met behulp van zoogdiercellen.

http://www.uva-aias.net/uploaded_files/regular/4028-J2000.pd...